SIA
PTX

Stancorp Investment Advisers’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Stancorp Investment Advisers’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$1K Hold
6
– – ﹤0.01% 689
2014
Q4 		$1K Buy
+6
New +$572 ﹤0.01% 685

Other funds holding PTX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

Stancorp Investment Advisers's PTX Position: Q1 2015 in Review

Stancorp Investment Advisers held its Pernix Therapeutics Holdings, Inc. (PTX) position steady in Q1 2015 at 6 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #689.

Stancorp Investment Advisers first reported a position in PTX in Q4 2014 and has held it in 2 quarters since. 117 funds tracked by Wall St. Rank hold PTX as of Q1 2015.

  • Stancorp Investment Advisers held 6 shares of Pernix Therapeutics Holdings, Inc. worth $1K as of Q1 2015.
  • Stancorp Investment Advisers left its Pernix Therapeutics Holdings, Inc. share count unchanged in Q1 2015.
  • Pernix Therapeutics Holdings, Inc. made up ﹤0.01% of Stancorp Investment Advisers's portfolio in Q1 2015, its #689 holding.
  • Stancorp Investment Advisers first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2014 and has held it in 2 quarters since.
  • 117 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.